13 research outputs found

    PG&E WaveConnect Program Final Report

    Full text link
    The PG&E WaveConnect project was intended to demonstrate the technical and economic viability of wave power in the open ocean adjacent to PG&E's service territory. WaveConnect was conceived as a multi-stage development process leading to long-term megawatt-scale wave power production. The first-stage tasks consisted of site selection, permitting, pilot plant design, and assessment of technology and commercial readiness. The second stage would have included development of infrastructure, undersea cabling, and deployment of wave energy conversion devices (WECs). In the third stage, the most promising WEC devices would have been deployed in larger quantities and connected to the grid. This report documents the findings of Stage One. Site Selection: After studying the wave energy potential, grid interconnection and other project infrastructure along the California coast, PG&E selected two sites: one near Eureka, called the Humboldt WaveConnect (HWC) project, and another near Vandenberg Air Force Base, called the Central Coast WaveConnect project (CCWC). Permitting: FERC issued PG&E preliminary permits for HWC in 2008 and for CCWC in 2010. PG&E chose to use FERC's Pilot Project Licensing Process, which was intended to streamline licensing to allow relatively quick and easy installation, operation, and environmental testing for pilot projects. Permitting, however, proved to be complicated, time-consuming and expensive, mainly because of the uncertain impacts of WEC devices. PG&E learned that even under the PPLP the project would still require a full analysis under CEQA, including an EIR, as well as Monitoring and Adaptive Management Programs and other requirements that had significant cost and scheduling implications. A majority of efforts were expended on permitting activities. Pilot Plant Design: PG&E prepared a conceptual design for a 5-MW pilot test facility at the Humboldt site, which consisted of an off-shore deployment area where WECs of different designs and from different device manufacturers could be tested. PG&E was to provide permitting, subsea cables, and on-shore facilities necessary to connect WaveConnect to an existing PG&E substation, while the WEC manufacturers would provide, operate and maintain their devices during the test period. Technology and Commercial Readiness: PG&E issued a Request for Information to the wave power industry to assess the technical and commercial capabilities of WEC manufacturers. Sixteen manufacturers responded, representing the four best-known and most mature designs. PG&E found that WECs are early-stage devices with evolving designs and little real-world operating experience. These characteristics made environmental impacts difficult to assess, which complicated permitting efforts. It also made a megawatt-scale demonstration project difficult to support because early stage WECs are costly and have limited track records for performance and reliability. Results: PG&E withdrew its FERC DPLA for HWC in November 2010 and surrendered its preliminary permit for CCWC in May 2011, effectively discontinuing the project for the following combination of reasons: Permitting issues were much more challenging than originally anticipated. Stage One project funding of 6 million proved insufficient to complete the necessary development and permitting work. During Stage One development, PG&E determined that permitting costs would be 2 million to 5milliongreaterthanoriginallybudgeted.Thecostofdevelopingafive−year,5−MWpilotprojectatHumboldtBayismuchgreaterthanthe5 million greater than originally budgeted. The cost of developing a five-year, 5-MW pilot project at Humboldt Bay is much greater than the 15 million to 20 million originally estimated. Even assuming that vendors provide WEC devices at no cost to the utility, which was the proposed strategy with WaveConnect, PG&E concluded that a pilot project comparable to HWC would cost approximately 47 million. If WEC devices were purchased for such a project, its total cost would be on the order of 90million.Itisunclearwhenorifwavepowerwillbecomecompetitivewithrenewableenergyalternatives.Significantadditionalinvestmentindesign,testinganddemonstrationwillbeneededtoimprovedesignsandreducecosts.Usingavendor−providedinstalledcostgoalof90 million. It is unclear when or if wave power will become competitive with renewable energy alternatives. Significant additional investment in design, testing and demonstration will be needed to improve designs and reduce costs. Using a vendor-provided installed cost goal of 2500/kW for mature WECs in five to 10 years, PG&E concluded that their LCOE would be in the range of 175−175-250/MWh, which is not competitive with current or near-term renewable alternatives such as wind or solar photovoltaics. Although PG&E discontinued the project and no WEC devices were deployed, WaveConnect advanced PG&E's understanding of the technological, engineering, permitting, environmental, economic, stakeholder, and related issues involved in undertaking any wave power project now or in the future. As WEC technologies mature, and regulatory and permitting agencies grow more familiar with their environmental impacts, PG&E believes that wave power will merit further evaluation, demonstration and deployment

    Finishing the euchromatic sequence of the human genome

    Get PDF
    The sequence of the human genome encodes the genetic instructions for human physiology, as well as rich information about human evolution. In 2001, the International Human Genome Sequencing Consortium reported a draft sequence of the euchromatic portion of the human genome. Since then, the international collaboration has worked to convert this draft into a genome sequence with high accuracy and nearly complete coverage. Here, we report the result of this finishing process. The current genome sequence (Build 35) contains 2.85 billion nucleotides interrupted by only 341 gaps. It covers ∼99% of the euchromatic genome and is accurate to an error rate of ∼1 event per 100,000 bases. Many of the remaining euchromatic gaps are associated with segmental duplications and will require focused work with new methods. The near-complete sequence, the first for a vertebrate, greatly improves the precision of biological analyses of the human genome including studies of gene number, birth and death. Notably, the human enome seems to encode only 20,000-25,000 protein-coding genes. The genome sequence reported here should serve as a firm foundation for biomedical research in the decades ahead

    Factors Associated with Revision Surgery after Internal Fixation of Hip Fractures

    Get PDF
    Background: Femoral neck fractures are associated with high rates of revision surgery after management with internal fixation. Using data from the Fixation using Alternative Implants for the Treatment of Hip fractures (FAITH) trial evaluating methods of internal fixation in patients with femoral neck fractures, we investigated associations between baseline and surgical factors and the need for revision surgery to promote healing, relieve pain, treat infection or improve function over 24 months postsurgery. Additionally, we investigated factors associated with (1) hardware removal and (2) implant exchange from cancellous screws (CS) or sliding hip screw (SHS) to total hip arthroplasty, hemiarthroplasty, or another internal fixation device. Methods: We identified 15 potential factors a priori that may be associated with revision surgery, 7 with hardware removal, and 14 with implant exchange. We used multivariable Cox proportional hazards analyses in our investigation. Results: Factors associated with increased risk of revision surgery included: female sex, [hazard ratio (HR) 1.79, 95% confidence interval (CI) 1.25-2.50; P = 0.001], higher body mass index (fo

    The Trail, 1965-03-19

    Get PDF
    https://soundideas.pugetsound.edu/thetrail_all/4034/thumbnail.jp

    Nutzenbewertung von Trainingsinterventionen für die Sturzprophylaxe bei älteren Menschen - eine systematische Übersicht auf der Grundlage systematischer Übersichten

    No full text

    Fixation using alternative implants for the treatment of hip fractures (FAITH): design and rationale for a multi-centre randomized trial comparing sliding hip screws and cancellous screws on revision surgery rates and quality of life in the treatment of femoral neck fractures

    No full text
    corecore